SILVER LIFE CO.,LTD. (9262) AI Stock Analysis

• Market Cap: ¥9.36B
• Dividend Yield: 1.88%
• Average Volume (3M): 37.85K
• Price to Earnings (P/E): 13.3
• Beta (1Y): 0.70
• Revenue Growth: 10.06%
• EPS Growth: 4.96%
• Country: JP
• Employees: 305
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Personal Products & Services
• EPS (TTM): 20.65
• Shares Outstanding: 10,907,600
• 10 Day Avg. Volume: 21,360
• 30 Day Avg. Volume: 37,850
• PEG Ratio: 2.27
• Price to Book (P/B): 1.14
• Price to Sales (P/S): 0.53
• P/FCF Ratio: 12.92
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 75 Outperform
• Price Target: ¥975.00 ▲(12.33% Upside)

Silver Life Co., Ltd. has a solid overall stock score driven by strong financial performance and positive technical indicators. The company's reasonable valuation further supports its attractiveness. While there is room for improvement in profitability and cash flow conversion, the stock's current momentum and fair valuation make it a compelling option in the Personal Products & Services industry.

SILVER LIFE CO.,LTD. Business Overview & Revenue Model

Company Description

SILVER LIFE CO., LTD. (9262) is a company based in Japan that operates primarily in the healthcare and wellness sectors. The company focuses on providing health management services and products that cater to the aging population, including health supplements, medical equipment, and lifestyle support services. SILVER LIFE aims to enhance the quality of life for senior citizens through innovative solutions tailored to their needs.

How the Company Makes Money

SILVER LIFE generates revenue primarily through the sale of health supplements and medical devices designed for elderly care. The company also provides subscription-based health management services and partners with healthcare institutions and insurance companies to offer integrated health solutions. Key revenue streams include direct product sales, service subscriptions, and partnerships that may involve co-marketing agreements or bundled service offerings. Additionally, SILVER LIFE may benefit from government initiatives aimed at improving senior health care, creating further opportunities for earnings.

SILVER LIFE CO.,LTD. Financial Statement Overview

Summary

Silver Life Co., Ltd. demonstrates strong revenue growth and operational efficiency, with stable margins and a solid balance sheet. While the company has improved its leverage position, there is room for enhancing net profitability and cash flow conversion. Overall, the financial health is robust, but attention to profitability and cash flow metrics could further strengthen the company's financial position.

Income Statement

Silver Life Co., Ltd. has shown consistent revenue growth over the years, with a 5.87% increase in the most recent year. The gross profit margin has improved to 33.72%, indicating efficient cost management. However, the net profit margin slightly decreased to 4.71%, suggesting some pressure on net profitability. The EBIT and EBITDA margins are stable, reflecting solid operational performance.

Balance Sheet

The company's debt-to-equity ratio has improved to 0.24, indicating a strong balance sheet with manageable leverage. The equity ratio is healthy, showing that a significant portion of the company's assets is financed by equity. However, the return on equity has slightly decreased, suggesting a need for improved profitability from equity investments.

Cash Flow

Operating cash flow has increased, supporting the company's operations. The free cash flow has grown significantly, but the free cash flow to net income ratio remains moderate at 0.40, indicating room for improvement in converting net income into free cash flow. The operating cash flow to net income ratio is strong, reflecting good cash generation relative to net income.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	14.43B	14.92B	13.56B	12.27B	11.22B	10.05B
Gross Profit	4.87B	5.03B	4.37B	3.71B	3.09B	2.72B
EBITDA	1.72B	1.95B	1.74B	1.53B	1.21B	1.19B
Net Income	638.77M	702.58M	668.05M	602.57M	401.89M	546.11M
Balance Sheet
Total Assets	10.16B	10.45B	9.88B	9.56B	8.86B	8.26B
Cash, Cash Equivalents and Short-Term Investments	1.37B	1.60B	1.27B	1.51B	1.47B	1.47B
Total Debt	1.77B	1.69B	1.71B	1.95B	2.19B	1.93B
Total Liabilities	3.42B	3.48B	3.45B	3.65B	3.56B	3.34B
Stockholders Equity	6.74B	6.97B	6.42B	5.92B	5.30B	4.93B
Cash Flow
Free Cash Flow	0.00	613.25M	152.13M	242.61M	-329.89M	-2.33B
Operating Cash Flow	0.00	1.52B	1.32B	1.20B	1.21B	369.40M
Investing Cash Flow	0.00	-1.00B	-1.16B	-937.87M	-1.47B	-2.69B
Financing Cash Flow	0.00	-185.57M	-400.55M	-230.88M	263.50M	1.95B

SILVER LIFE CO.,LTD. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 868.00
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9262, the sentiment is Positive. The current price of 868 is above the 20-day moving average (MA) of 861.10, above the 50-day MA of 844.38, and above the 200-day MA of 750.65, indicating a bullish trend. The MACD of 0.50 indicates Positive momentum. The RSI at 54.31 is Neutral, neither overbought nor oversold. The STOCH value of 65.84 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:9262.

SILVER LIFE CO.,LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9262	75 Outperform	¥9.36B	13.27	―	1.88%	10.06%	4.96%
2485	74 Outperform	¥11.21B	9.25	―	3.97%	25.26%	65.66%
7358	74 Outperform	¥14.05B	15.42	―	2.78%	7.89%	-12.90%
7040	71 Outperform	¥5.91B	7.07	―	3.42%	3.40%	-25.64%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
7578	44 Neutral	¥2.12B	―	―	―	-18.74%	-1062.47%

SILVER LIFE CO.,LTD. Corporate Events

Silver Life Co., Ltd. Reports Positive Financial Growth for Fiscal Year 2025

Silver Life Co., Ltd. reported a positive financial performance for the fiscal year ending July 31, 2025, with a notable increase in net sales and profits compared to the previous year. The company achieved a 10.1% rise in net sales and a 10.7% increase in operating profit, indicating a strong operational year. The financial outlook for the upcoming year also appears optimistic, with forecasts predicting continued growth in sales and profits, which could strengthen the company’s market position and benefit stakeholders.

The most recent analyst rating on (JP:9262) stock is a Hold with a Yen801.00 price target. To see the full list of analyst forecasts on SILVER LIFE CO.,LTD. stock, see the JP:9262 Stock Forecast page.